Ameliorating Drug Shortages in Pakistan (Policy)

Shahid Mehmood

The Pakistan Development Review, 2022, vol. 61, issue 1, 145-148

Abstract: In mid-March 2022, a letter by Pakistan Young Pharmacist Association (PYPA) caught the headline of major newspapers in Pakistan. The letter, written in the context of the prevalent shortage of paracetamol, more or less alleged that the drug manufacturing companies were deliberately causing the shortages. They argued that drug manufacturers wanted to compel customers to buy a higher dose of the said drug (665 mg) since it had a significantly higher price than lower doses. The letter again brings to light the critical (but lesser discussed) issue of persistent drug shortages in Pakistan. Every year, critically needed drugs tend to vanish off the shelves, to be either found in black or imported to meet shortages (the below table contains a few sample cases of shortages since two decades).

Keywords: Drug Shortages (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://pide.org.pk/pdfpdr/2022/145-148.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pid:journl:v:61:y:2022:i:1:p:145-148

Access Statistics for this article

More articles in The Pakistan Development Review from Pakistan Institute of Development Economics Contact information at EDIRC.
Bibliographic data for series maintained by Khurram Iqbal ().